Previous Article | Next Article 
Journal of Bacteriology, December 1999, p. 7285-7290, Vol. 181, No. 23
0021-9193/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
A Periplasmic Location Is Essential for the Role of
the ApbE Lipoprotein in Thiamine Synthesis in Salmonella
typhimurium
Brian J.
Beck and
Diana M.
Downs*
Department of Bacteriology, University of
Wisconsin-Madison, Madison, Wisconsin 53706
Received 6 July 1999/Accepted 16 September 1999
 |
ABSTRACT |
ApbE is a lipoprotein in Salmonella typhimurium, and
mutants unable to make this protein have a reduced ability to make
thiamine (vitamin B1) and require it as a supplement for
optimal growth in minimal glucose medium. Polyclonal antibodies
specific to ApbE were used to determine that wild-type ApbE is located
exclusively in the inner membrane. The periplasmic, monotopic topology
of ApbE was determined by using computer-based hydrophobicity plots, LacZ and PhoA gene fusions, and proteinase protection experiments. This
extracellular location of ApbE is required for its function, since a
cytoplasmic form (ApbEcyto) did not allow an
apbE mutant to grow in the absence of thiamine. A
periplasmic form of ApbE (ApbEperi) lacking the lipoprotein
modification allowed an apbE mutant to grow in the absence
of thiamine, indicating that soluble ApbE could function in thiamine
synthesis and that lipoation and membrane association were not
required. Alteration of the amino acid implicated in membrane sorting
for other lipoproteins did not result in a relocalization of ApbE to
the outer membrane, suggesting that additional sorting determinants
exist for ApbE.
 |
INTRODUCTION |
Thiamine is synthesized in
Salmonella typhimurium by a low-flux biosynthetic pathway
that has recently been shown to be sensitive to a number of subtle
metabolic perturbations (7, 8, 10, 11, 13). This sensitivity
is manifested as a thiamine auxotrophy and has been exploited to
identify new aspects of metabolic integration. Through this approach
integration between thiamine synthesis, carbon catabolism, coenzyme A
biosynthesis, and the redox state of the cell has been uncovered
(7, 8, 10, 11, 13). It was possible to rationalize many of
the metabolic interactions, since precursors to vitamin biosynthetic
pathways are often metabolites diverted from major anabolic-catabolic
pathways (5, 11, 16, 26).
A number of loci that affect thiamine synthesis have been identified
based on a thiamine requirement of the respective mutants. Unlike those
alluded to above, several of these loci were uncharacterized open
reading frames, and thus an explanation for the resulting thiamine
requirement was not readily apparent. Of significance to this study was
the identification of two such loci, rseC (3) and
apbE (4), whose products have been shown to be
membrane proteins. The latter locus encodes a 36-kDa lipoprotein. These loci do not appear to encode biosynthetic enzymes involved directly in
thiamine synthesis, although membrane association of such enzymes might
not be unexpected. Compartmentalization of enzymes to the cytoplasm,
cytoplasmic membrane (the inner or outer face), periplasm, or outer
membrane has been shown to allow closer interactions with substrates,
and such compartmentalization might be warranted when substrate levels
are relatively low, as would be expected in a low-flux pathway such as
those involved in vitamin synthesis (20).
Membrane proteins are involved in a wide range of cellular functions,
including import and export of compounds, sensing environmental cues,
and electron transfer for energy generation and redox catalysis. Lipoproteins represent a specific class of membrane proteins that are
anchored to the lipid bilayer through their lipid modification. ApbE is
the first lipoprotein whose absence results in a nutritional requirement. Although the number of known bacterial lipoproteins has
increased to more than 130, the membrane location, topology, and
function of most lipoproteins remain unknown (24, 28, 31).
Experiments presented here initiate the structural characterization of
the ApbE lipoprotein and reveal it to be completely exposed to the
periplasmic space but anchored to the inner membrane. Additionally, we
show that the function of ApbE in thiamine synthesis is dependent on
its extracellular location. Further, the membrane sorting signals
reported for other lipoproteins are not sufficient to alter the
location of ApbE, suggesting additional determinants contribute to
membrane localization of lipoproteins.
 |
MATERIALS AND METHODS |
Strains, media, and growth conditions.
All strains used in
this study are derivatives of S. typhimurium LT2 (except
Escherichia coli CC118) and are listed with their genotypes
in Table 1. Tn10d(Tc) refers
to the transposition-defective mini-Tn10 described by Way et
al. (30). Growth curves were performed by using cells that
were grown overnight in rich medium and then resuspended in saline.
Cell suspensions (10 µl) were used to inoculate 190 µl of medium in
individual wells of a 96-well microtiter dish. Growth was monitored as
the increase in absorbance at 650 nm by using a SpectraMAX Plus
Microplate Spectrophotometer (Molecular Devices, Sunnyvale, Calif.).
The culture plate was maintained at 37°C with periodic shaking for
aeration. NCE medium supplemented with MgSO4 (1 mM)
(9) and glucose (11 mM) was used as minimal medium. Difco
nutrient broth (8 g/liter) with NaCl (5 g/liter) added was used as rich
medium. Difco BiTek agar was added to a final concentration of 1.5%
for solid medium. Unless otherwise stated, the final concentrations of
adenine and thiamine were 0.4 mM and 100 nM, respectively. The final
concentrations of antibiotics in rich/minimal medium were as follows:
tetracycline (20/10 µg/ml), kanamycin (50/125 µg/ml), ampicillin
(30/15 µg/ml), and chloramphenicol (20/4 µg/ml).
Plasmid construction. (i) Cytoplasmic ApbE
(ApbEcyto).
The coding sequence of the apbE
gene excluding the signal sequence (amino acids 1 to 20) was amplified
from the S. typhimurium LT2 chromosome by standard PCR
techniques. An NdeI site was designed into the upstream
(5'-end) primer and the downstream (3'-end) primer contained the stop
codon for apbE. After blunt-end ligation into pSU19 (pApbE9)
the 1.1-kb NdeI-HindIII fragment was cloned into pET20b (Novagen, Madison, Wis.), yielding pApbE10. The full-length apbE gene was cloned into pET20b by a similar method with a
distinct upstream primer and resulted in pApbE12.
(ii) Periplasmic ApbE (ApbEperi).
The coding
sequence of the apbE gene that corresponded to amino acid
positions 20 to 350 was amplified from the S. typhimurium chromosome by using standard PCR techniques. The upstream (5') primer
contained a PstI site which replaced the cysteine at
position 20 with an alanine; the downstream (3') primer was as
described above. The amplified product was ligated into the
SmaI site of pSU19, yielding pApbE(C20A). The
ompF sequence for the OmpF-ApbE fusion was generated by
annealing complementary sequences of the OmpF signal peptide that
contained NdeI and PstI sites. The DNA encoding
the OmpF signal peptide was ligated into the SmaI site of
pSU19, yielding pOmpF. A 0.9-kb PstI fragment from
pApbE(C20A) was ligated into pOmpF that had been digested with
PstI. Sequence analysis was used to confirm a clone with the
desired ompF::apbE(C20A) fusion. This
fusion was then cloned into pT7-7 as a
NdeI-HindIII fragment, resulting in pApbE14.
(iii) ApbE(D21S).
The aspartate residue at position 21 of
ApbE (+2 in the processed protein) was changed to a serine by the
megaprimer method of Barik (1). Chromosomal DNA from
S. typhimurium LT2 was used as the DNA template in this
two-step amplification method. All plasmid constructs were confirmed by
sequence analysis.
Construction of ApbE-His6 and Western analysis.
A C-terminal His6 fusion to ApbE lacking the leader
sequence was constructed by standard PCR amplification with primers
specific to the ends of apbE. The appropriate fragment was
cloned into the NdeI-HindIII sites of pET20b
and protein expression was confirmed utilizing methods described by the
manufacturer (Novagen). Purification of ApbE-His6 was
achieved by passing extracts expressing the fusion protein over an
Ni2+-affinity column (Novagen). ApbE-His6 was
obtained in >90% homogeneity by purification under denaturing
conditions. Rabbit polyclonal antibodies against ApbE-His6
were generated at the animal care unit of the University of Wisconsin
Medical School. Antisera was prepared and titered according to the
method of Harlow and Lane (14). Standard sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) was used and
Western analysis were performed as described previously with alkaline
phosphatase-conjugated goat anti-rabbit immunoglobulin G (Promega,
Madison, Wis.) used to detect anti-ApbE bound to the membrane support
(14).
Isolation of apbE::phoA
fusions.
Plasmid pApbE1 was introduced into E. coli
CC118. The method of Manoil and Beckwith (17) was used to
isolate alkaline phosphatase (phoA) gene fusions to
apbE, in addition to unsuccessful attempts to isolate
-galactosidase (lacZ) gene fusions to the same gene. PhoA
insertions in the apbE gene were identified on agar plates supplemented with 40 µg of the chromagenic indicator XP
(5-bromo-4-chloro-3-indolyl phosphate; Fluka, Milwaukee, Wis.) per ml.
The location of the insertions was estimated by PCR amplification with
a primer specific to the sequence upstream of the 5' end of the
apbE gene (5'-TATTCCGGCGTACAAATACG-3') and a
primer that annealed within the TnphoA sequence
(5'-AATATCGCCCTGAGCAGCCCG-3'). These primers were also used
to sequence the junction of the fusions and thus precisely determine
the location of the fusion. The alkaline phosphatase activities of the
E. coli CC118 cells expressing ApbE::PhoA fusions
were determined by the procedure described by Brickman, with a control
strain containing no fusion set to zero (6).
Protease accessibility of ApbE in intact spheroplasts.
The
accessibility of ApbE from S. typhimurium LT2 whole cells,
spheroplasts (generated as described by Osborn and Munson
[22]), and lysed spheroplasts to proteinase K was
determined by a modification of the method of Randall and Hardy
(25). After a 20-min treatment with proteinase K (100 µg/ml) at 4°C, protein was precipitated with 5% trichloroacetic
acid. Each sample (equivalent to 0.05 A650) was
analyzed by SDS-PAGE and Western hybridization.
Protein analysis and cell fractionation.
Separation of cell
protein into cytoplasmic and total membrane fractions and subsequently
into inner and outer membrane fractions was carried out as described by
Osborn and Munson (22). Briefly, cells were grown to mid-log
phase (ca. 55 Klett units [red filter]), spheroplasted, and lysed by
osmotic shock. Low-speed centrifugation was used to remove unbroken
cells, and then the supernatant was centrifuged at 40,000 rpm for
2 h in a Beckman 70 Ti rotor. The pellet was saved as the total
membrane fraction, and the supernatant contained the
cytoplasmic-periplasmic fraction. The total membrane fraction was
loaded onto a 50 to 35% stepwise sucrose gradient with a 55% sucrose
cushion and centrifuged at 36,000 rpm for 16 h in a Beckman SW40
Ti rotor. Fractions were collected dropwise, and the location of the
inner and outer membranes within the gradient was visualized by
Coomassie staining and confirmed by detecting NADH oxidase activity
(29) and 2-keto-deoxyoctonate (data not shown)
(15), respectively.
Isolation of periplasmic and cytoplasmic fractions was performed by a
modification of the osmotic shock procedures developed
by Neu and
Heppel (
21) and Thorstenson et al. (
29). A 5-ml
culture was grown in minimal medium to mid-log phase, and 1.0
ml of the
cells was resuspended in 100 µl of 0.5 M sucrose-0.2
M Tris-0.5 mM
EDTA and kept on ice for 15 min. Then, 400 µl of
TE (10 mM Tris [pH
8.0], 1 mM EDTA) was mixed into the suspension,
which was kept on ice
for 30 min. The cells were pelleted, and
the supernatant was saved as
the periplasmic fraction, while the
pellet was further processed. The
cell pellet was washed and resuspended
in 0.1 M sucrose-40 mM
Tris-0.1 mM EDTA and sonicated for 10 s
at a 50% duty cycle by
using a model 550 sonic dismembrator (Fisher,
Itasca, Ill.), and a
low-speed centrifugation was used to remove
the unbroken cells. The
supernatant was centrifuged at 100,000
rpm for 30 min in a Beckman TLA
100.2 rotor. The supernatant contained
the cytoplasmic fraction, and
the pellet was washed once with
TE buffer to remove any contaminating
periplasmic and peripheral
proteins and then pelleted again. The final
pellet was saved as
the total membrane fraction. The relative purity of
the periplasmic
and membrane fractions was determined by using

-lactamase or
NADH oxidase, respectively, as marker
enzymes.
 |
RESULTS AND DISCUSSION |
ApbE is located in the inner membrane.
Our characterization of
ApbE was driven by two assumptions: (i) by understanding its location
and structural features, we could better address the role of this
protein in thiamine synthesis, and (ii) we could further the general
understanding of bacterial lipoproteins by topological and
mutational characterization of another lipoprotein. Analysis of ApbE
sequence in the context of characterized lipoproteins suggested that
the mature protein would be lipoated and localized to the inner
membrane. Immunoblot analyses were performed on wild-type and mutant
strains to validate and extend this prediction. Comparison of
whole-cell extracts of strain DM271(apbE) and wild-type
strain LT2 blotted with antibodies specific to ApbE identified an
appropriately sized band that was detected in the LT2 extract but not
in extracts from the apbE mutant strain (data not shown).
From these comparisons, we concluded this band corresponded to ApbE.
Western blot analyses with LT2 with ApbE-specific antisera showed that
ApbE clearly separated with the membrane fraction,
and none was
detected in the soluble fraction (Fig.
1A). When
the membrane was separated into
inner and outer membrane fractions,
ApbE was found exclusively in the
inner membrane. Biochemical
characterization of the membrane separation
is documented in Fig.
1B and is representative of the separations in
subsequent experiments.

View larger version (22K):
[in this window]
[in a new window]
|
FIG. 1.
Chromosomally encoded ApbE from S. typhimurium LT2 is located in the inner membrane. (A) Immunoblot
of whole-cell (WC), soluble cytoplasmic and periplasmic (SOL), total
membrane (TM), inner membrane (IM), and outer membrane (OM) fractions.
Cellular fractions were prepared as described in Materials and Methods.
Western analysis with polyclonal antibodies against ApbE (1:5,000
dilution) was performed (14). (B) Representative membrane
separation profile from S. typhimurium LT2. Inner and outer
membranes were fractionated by sucrose density equilibration. The
protein concentration, NADH oxidase activity, and sucrose concentration
values are shown. The fractions pooled and used in Fig. 1A are
indicated.
|
|
ApbE is exposed on the periplasmic face of the inner membrane.
Although the lipoated N terminus of ApbE would be expected to be
located in the inner membrane (31), the presence of a
cytoplasmic domain was tested. Based on analyses with a number of
computer programs (i.e., TMPRED, TMAP, and Kyte-Doolittle), ApbE does
not have an apparent membrane-spanning region (data not shown),
suggesting that the entire ApbE protein was located in the periplasm
with the fatty acids tethering it to the cell membrane.
Two lines of genetic evidence confirmed that ApbE did not contain a
cytoplasmic domain. Attempts to isolate translational
fusions between
ApbE and LacZ, producing functional

-galactosidase
that would
indicate a cytoplasmic domain, were unsuccessful. Conversely,
five
active PhoA fusions to ApbE were isolated, and the fusion
junctions
determined by DNA sequencing (Fig.
2A).
Since the activity
of alkaline phosphatase requires the protein to be
extracellular,
these results were consistent with the topology
predicted by computer
analysis.

View larger version (29K):
[in this window]
[in a new window]
|
FIG. 2.
ApbE is periplasmically located. (A) The predicted
monotopic structure of ApbE anchored in the outer leaflet of the inner
membrane lipid bilayer is schematically shown. Arrows indicate the
location of active alkaline phosphatase (PhoA) fusions to ApbE encoded
by pApbE1, and the number below the shaded box indicates the amino acid
of ApbE that immediately proceeds the fusion junction. The numbers in
the shaded boxes represent the relative PhoA activity (in units per
minute per optical density at 650 nm) of each fusion compared to a
control containing an out-of-frame PhoA fusion. (B) Immunoblot showing
the proteinase K accessibility of chromosomally encoded ApbE in whole
cells, spheroplasts, and lysed spheroplasts. Samples were treated with
(+) or without ( ) proteinase K (100 µg/ml). The proteins in each
sample (equivalent to 0.05 A650) were separated
by SDS-PAGE and immunoblotted with a 1:5,000 dilution of ApbE
antisera.
|
|
Independent verification of periplasmic exposure was sought by
measuring the accessibility of ApbE to proteinase K. The ability
of
proteinase K to degrade ApbE from
S. typhimurium LT2 whole
cells, spheroplasts, and lysed spheroplasts was determined and
visualized by SDS-PAGE, followed by Western hybridization (Fig.
2B). As
anticipated, ApbE in whole cells was protected from proteinase
K
digestion, presumably by the intact outer membrane. ApbE in
spheroplasts was completely sensitive to proteinase K digestion.
Taken
together, the results in this section clearly demonstrated
a
periplasmic location for
ApbE.
The periplasmic location of ApbE is required for its function.
Having identified the subcellular location of ApbE, we took advantage
of the nutritional defect of an apbE mutant to explore the
correlation of function with location. The extent of the nutritional defect caused by an apbE mutation is dependent on both the
genetic background and the carbon source in the growth medium
(4). Specifically, when there is low carbon flux through the
purine biosynthetic pathway (e.g., purF), ApbE is required
for thiamine synthesis regardless of the carbon source, hence its
apb designation (23). In the nutritional studies
described here, we took advantage of the fact that apbE
mutations also result in a thiamine auxotrophy in an otherwise
wild-type genetic background when glucose is the sole carbon and energy source.
The first experiment tested whether the role of ApbE in thiamine
synthesis required export to the membrane or whether the
protein
might have a cytoplasmic function prior to its export.
Two
strains, carrying either pApbE10 (expressing ApbE without
the
signal peptide sequence and lipoation site) or pApbE12 (encoding
the
full-length ApbE protein) as the only source of ApbE, were
assessed for
their growth in the absence of thiamine and the cellular
location of
the respective plasmid-encoded ApbE. Data from Western
blot analysis
(Fig.
3B) confirmed that when the signal
peptide
sequence was removed (pApbE10) ApbE was located completely in
the cytoplasm, whereas wild-type ApbE (pApbE12) was located solely
in
the membrane fraction. Significantly, the growth data in Fig.
3A showed
that the leaderless construct was unable to restore
thiamine-independent growth to an
apbE mutant, while the
wild-type
protein completely complemented the growth defect (Fig.
3A,
left
panel). While we cannot eliminate the possibility that the
cytoplasmic
ApbE was partially functional, it did not result in
significantly
more thiamine-independent growth than strain DM271
carrying the
vector alone (data not shown).

View larger version (19K):
[in this window]
[in a new window]
|
FIG. 3.
ApbE requires a signal peptide for membrane association
and function in thiamine synthesis. (A) The growth of strain DM271
(apbE) carrying pApbE12, encoding wild-type ApbE ( ), or
pApbE10, encoding ApbE without the lipoprotein signal peptide ( ), is
shown. Cells were grown in minimal medium with glucose as the sole
carbon and energy source and supplemented with 100 nM thiamine where
indicated. (B) Immunoblot showing the cellular location of ApbE
produced by pApbE10 and pApbE12. Cellular fractions were isolated as
described in Materials and Methods. Abbreviations: WC, whole-cell
fraction; SOL, soluble cytoplasmic and periplasmic proteins; TM, total
membrane proteins.
|
|
Although the results from the above experiment did not distinguish
between a requirement for location and a role for the signal
peptide or
lipoation site in function, the simplest conclusions
from this
experiment were that (i) membrane association of ApbE
required the
presence of the signal peptide and that (ii) membrane
association
and/or extracellular localization was necessary for
function. To
determine whether ApbE function required association
with the membrane,
a periplasmic form of ApbE was constructed
by replacing the ApbE
lipoprotein signal peptide with the signal
peptide of OmpF
(ApbE
peri). Cleavage of the OmpF signal peptide
should
result in the release of ApbE into the periplasm, where
its function
could be assessed in the absence of membrane association
as had been
done with AcrA, a component of the multi-drug efflux
complex AcrAB-TolC
of
E. coli (
33). As shown in Fig.
4, plasmid
pApbE
peri restored
wild-type thiamine-independent growth to strain
DM271 (
apbE)
(Fig.
4A, left panel). Western blot analysis of fractions
from cells
carrying pApbE
peri confirmed that ApbE
peri was
localized
to the periplasm and was completely absent from the membrane
fraction
(Fig.
4B). We noted two additional features of the Western
blot
analyses with pApbE
peri. First, unlike cells
expressing wild-type
ApbE, extracts from cells containing
pApbE
peri contained a significant
amount of unprocessed
ApbE. Second, a small but detectable amount
of ApbE
peri was
located in the soluble, cytoplasmic fraction.
The presence of ApbE in
this fraction is most likely ApbE
peri that was not released
by the osmotic shock but was released upon
sonic disruption of the
cells. We discounted the role of ApbE
in this fraction in the
functional studies since the experiments
described above showed that
ApbE located in the cytoplasm was
unable to restore thiamine synthesis
in an
apbE mutant. From this
experiment we concluded that
wild-type ApbE does not require membrane
anchorage to fulfill its role
in thiamine synthesis.

View larger version (21K):
[in this window]
[in a new window]
|
FIG. 4.
A periplasmic form of ApbE complements the thiamine
requirement of an apbE mutant. (A) Growth of strain DM271
(apbE) carrying pApbEperi ( ) or pApbE12 that
produces wild-type ApbE ( ) in minimal glucose medium supplemented
with 10 nM thiamine where indicated. (B) Immunoblot showing the
cellular location of ApbE and ApbEperi expressed from
pApbE12 and pApbEperi, respectively. Cellular fractions
were isolated as described in Materials and Methods. Abbreviations: WC,
whole-cell proteins; CYT, cytoplasmic proteins; PERI, periplasmic
proteins; TM, total membrane proteins.
|
|
The above conclusion raises questions about the role of lipoation of
ApbE. The functional purpose of a lipid modification
is most obvious
with gram-positive organisms that lack an outer
membrane
(
28). In these organisms, the fatty acylations serve
as an
anchor for extracellular proteins. However, in gram-negative
organisms
the presence of an outer membrane may minimize the need
for a membrane
anchor. Perhaps the lipid anchor serves to optimally
localize a
protein, thus increasing its potential for interaction
with the
respective extracellular or membrane components. Such
a model suggests
that the lipoated form of the protein would be
more efficient than the
periplasmic form, a prediction that cannot
be tested currently because
of the lack of assay for ApbE
function.
The +2 amino acid is not sufficient to determine membrane
target.
An extension of the above experiment was to determine
whether ApbE functioned when transported to the outer membrane. Such a
result would impact the kind of models we could consider for the
function of ApbE in thiamine synthesis. As noted previously, ApbE
contains an aspartate residue at the +2 position in the processed protein (position 21 in the full-length protein). The lipoprotein studies of Yamaguchi et al. (32), Gennity and Inouye
(12), and Matsuyama et al. (18, 19) predicted
that substitution of a serine residue for this aspartate would target
ApbE to the outer membrane. Construction of such a mutant was done to
(i) test the significance of this consensus amino acid in another lipoprotein and (ii) if possible address the function of ApbE located
in the outer membrane. Oligonucleotide-directed site-specific mutagenesis was used to generate a serine-to-aspartate substitution at
position 21 in the full-length protein (+2 in the mature protein), and
the resulting mutant ApbE protein was designated ApbE(D21S). The gene
encoding the ApbE(D21S) mutant protein was cloned into pSU19
(2).
Growth analyses determined that ApbE(D21S) fully restored
thiamine-independent growth to strain DM271(
apbE). This
result demonstrated
that the D21S substitution did not significantly
impair the function
of the protein compared to wild-type ApbE (µ = 0.45 versus 0.53
h
1, respectively, in the absence of
thiamine). Unexpectedly, Western
blot analyses showed that ApbE(D21S)
was located only in the inner
membrane, a location indistinguishable
from the location of the
wild-type protein (data not shown). The fact
that no ApbE(D21S)
was detected in the outer membrane demonstrated
that, in contrast
to some other lipoproteins, in ApbE the +2 position
is not the
determinant for outer membrane targeting. Efforts by Gennity
and
Inouye (
12) indicate that the amino acids adjacent to
position
+2 (positions +3 and +4) may influence its role as the sorting
determinant. Specifically, a glutamate at position +3 was observed
to
cause minor but significant inner membrane retention of
Lipo-

-lactamase(E3),
a hybrid lipoprotein containing a serine at
position +2. Since
ApbE has a glutamate at position +3, the effect of
the serine
at position +2 could be minimized, but the complete lack of
movement
to the outer membrane strongly suggests that there are
additional
structural determinants involved in the inner membrane
localization
of
ApbE.
Conclusions.
At present our thinking is that ApbE participates
in thiamine synthesis indirectly, possibly as part of a complex that
mediates a redox-sensitive step in thiamine synthesis. This thinking
has been influenced by several recent results. First, RnfF, a membrane protein from Rhodobacter capsulatus, contains sequences
orthologous to both ApbE and RseC, an additional inner membrane protein
required for optimal thiamine synthesis in S. typhimurium
(3). The function of RnfF in R. capsulatus
physiology remains unclear but has been suggested to anchor a
membrane-associated protein complex that passes electrons to
nitrogenase for nitrogen fixation (27). Our finding that
RnfF can complement both apbE and rseC mutants (data not shown) makes it tempting to suggest that ApbE and/or RseC may
associate and perform a function similar to that of RnfF. Second,
recent work in the lab has identified additional loci affecting
thiamine synthesis that are involved in maintaining the redox
environment of the cell. Lastly, growth under anaerobic conditions
eliminates the need for ApbE in thiamine synthesis.
ApbE belongs to a growing class of proteins that are required for
thiamine synthesis under conditions that strain this biosynthetic
pathway (e.g., low flux through the purine biosynthetic pathway).
Thus,
these proteins may have a role in thiamine synthesis that
can be
satisfied by partially redundant cellular functions when
substrates are
plentiful. We suggest that many of the unknown
open reading frames in
various genome sequences may encode similar
redundancies and that their
metabolic role may be uncovered only
when the relevant pathways are
required to function efficiently.
Current work in the lab seeks to
address the specific thiamine
biosynthetic enzyme(s) affected in
apbE mutants and use this knowledge
to identify the
biochemical role of
ApbE.
 |
ACKNOWLEDGMENTS |
This work was supported by Hatch grant WIS3734 from the U.S.
Department of Agriculture and by National Institutes of Health grant
GM47296 to D.M.D.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: University of
Wisconsin-Madison, Department of Bacteriology, 1550 Linden Dr.,
Madison, WI 53706. Phone: (608) 265-4630. Fax: (608) 262-9865. E-mail: downs{at}bact.wisc.edu.
 |
REFERENCES |
| 1.
|
Barik, S.
1995.
Site-directed mutagenesis by double polymerase chain reaction.
Mol. Biotechnol.
3:1-7[Medline].
|
| 2.
|
Bartolomé, B.,
Y. Jubete,
E. Martinez, and F. de la Cruz.
1991.
Construction and properties of a family of pACYC184-derived cloning vectors compatible with pBR322 and its derivatives.
Gene
102:75-78[Medline].
|
| 3.
|
Beck, B. J.,
L. E. Connolly,
A. de las Penas, and D. M. Downs.
1997.
Evidence that rseC, a gene in the rpoE cluster, has a role in thiamine synthesis in Salmonella typhimurium.
J. Bacteriol.
179:6504-6508[Abstract/Free Full Text].
|
| 4.
|
Beck, B. J., and D. M. Downs.
1998.
The apbE gene encodes a lipoprotein involved in thiamine synthesis in Salmonella typhimurium.
J. Bacteriol.
180:885-891[Abstract/Free Full Text].
|
| 5.
|
Begley, T. P.,
D. M. Downs,
S. Ealick,
F. McLafferty,
D. van Loon,
S. Taylor,
H. Chiu,
C. Kinsland,
J. Reddick,
J. Xi, and N. Campobasso.
1999.
Thiamin synthesis in prokaryotes.
Arch. Microbiol.
171:293-300[Medline].
|
| 6.
|
Brickman, E., and J. Beckwith.
1975.
Analysis of the regulation of Escherichia coli alkaline phosphatase synthesis using deletions and 80 transducing phages.
J. Mol. Biol.
96:307-316[Medline].
|
| 7.
|
Christian, T., and D. M. Downs.
1999.
Defects in pyruvate kinase cause a conditional increase of thiamine synthesis in Salmonella typhimurium.
Can. J. Microbiol.
45:1-7[Medline].
|
| 8.
| Claas, K., S. Weber, and D. M. Downs. Mutants
defective in the energy conserving NADH dehydrogenase are unable to
utilize the oxidative pentose phosphate pathway. Submitted for
publication.
|
| 9.
|
Davis, R. W.,
D. Botstein, and J. R. Roth.
1980.
Advanced bacterial genetics.
Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y
|
| 10.
|
Enos-Berlage, J. L., and D. M. Downs.
1997.
Mutations in sdh (succinate dehydrogenase genes) alter the thiamine requirement of Salmonella typhimurium.
J. Bacteriol.
179:3989-3996[Abstract/Free Full Text].
|
| 11.
|
Frodyma, M., and D. M. Downs.
1998.
The panE gene, encoding ketopantoate reductase, maps at 10 minutes and is allelic to apbA in Salmonella typhimurium.
J. Bacteriol.
180:4757-4759[Abstract/Free Full Text].
|
| 12.
|
Gennity, J. M., and M. Inouye.
1991.
The protein sequence responsible for the lipoprotein membrane localization in Escherichia coli.
J. Biol. Chem.
266:16458-16464[Abstract/Free Full Text].
|
| 13.
| Gralnick, J., and D. M. Downs. Unpublished
data.
|
| 14.
|
Harlow, E., and D. Lane.
1988.
Antibodies: a laboratory manual.
Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y
|
| 15.
|
Keleti, G., and W. H. Lederer.
1974.
Handbook of micromethods for the biological sciences.
Van Nostrand Reinhold Co., New York, N.Y
|
| 16.
|
Lam, H. M., and M. E. Winkler.
1990.
Metabolic relationships between pyridoxine (vitamin B6) and serine biosynthesis in Escherichia coli K-12.
J. Bacteriol.
172:6518-6528[Abstract/Free Full Text].
|
| 17.
|
Manoil, C., and J. Beckwith.
1986.
A genetic approach to analyzing membrane protein topology.
Science
233:1403-1408[Abstract/Free Full Text].
|
| 18.
|
Matsuyama, S.,
T. Tajima, and H. Tokuda.
1995.
A novel periplasmic carrier protein involved in the sorting and transport of Escherichia coli lipoproteins destined for the outer membrane.
EMBO J.
14:3365-3372[Medline].
|
| 19.
|
Matsuyama, S.,
N. Yokota, and H. Tokuda.
1997.
A novel outer membrane lipoprotein, LolB (HemM) involved in the LolA (p20)-dependent localization of lipoproteins to the outer membrane of Escherichia coli.
EMBO J.
16:6947-6955[Medline].
|
| 20.
|
Mayer, F.
1993.
"Compartments" in the bacterial cell and their enzymes.
ASM News
59:346-350.
|
| 21.
|
Neu, H. C., and L. A. Heppel.
1965.
The release of enzymes from Escherichia coli by osmotic shock and during the formation of spheroplasts.
J. Biol. Chem.
240:3685-3692[Free Full Text].
|
| 22.
|
Osborn, M. J., and R. Munson.
1974.
Separation of the inner (cytoplasmic) and outer membranes of gram-negative bacteria.
Methods Enzymol.
31:642-652[Medline].
|
| 23.
|
Petersen, L. A.,
J. E. Enos-Berlage, and D. M. Downs.
1996.
Genetic analysis of metabolic crosstalk and its impact on thiamine synthesis in Salmonella typhimurium.
Genetics
143:37-44[Abstract].
|
| 24.
|
Pugsley, A. P.
1993.
The complete general secretory pathway in gram-negative bacteria.
Microbiol. Rev.
57:50-108[Abstract/Free Full Text].
|
| 25.
|
Randall, L. L., and S. J. S. Hardy.
1986.
Correlation of competence for export with lack of tertiary structure of the mature species: a study in vivo of maltose-binding protein in E. coli.
Cell
46:921-928[Medline].
|
| 26.
|
Rondon, M. R.,
J. R. Trzebiatowski, and J. C. Escalante-Semerena.
1997.
Biochemistry and molecular genetics of cobalamin biosynthesis, vol. 56.
Academic Press, Inc., New York, N.Y
|
| 27.
|
Schmehl, M.,
A. Jahn,
A. Meyer zu Vilsendorf,
S. Hennecke,
B. Masepohl,
M. Schuppler,
M. Marxer,
J. Oelze, and W. Klipp.
1993.
Identification of a new class of nitrogen fixation genes in Rhodobacter capsulatus: a putative membrane complex involved in electron transport to nitrogenase.
Mol. Gen. Genet.
241:602-615[Medline].
|
| 28.
|
Sutcliffe, I. C., and R. R. B. Russell.
1995.
Lipoproteins of gram-positive bacteria.
J. Bacteriol.
177:1123-1128[Free Full Text].
|
| 29.
|
Thorstenson, Y. R.,
Y. Zhang,
P. S. Olson, and D. Mascarenhas.
1997.
Leaderless polypeptides efficiently extracted from whole cells of osmotic shock.
J. Bacteriol.
179:5333-5339[Abstract/Free Full Text].
|
| 30.
|
Way, J. C.,
M. A. Davis,
D. Morisato,
D. E. Roberts, and N. Kleckner.
1984.
New Tn10 derivatives for transposon mutagenesis and for construction of lacZ operon fusions by transposition.
Gene
32:369-379[Medline].
|
| 31.
|
Wu, H. C.
1996.
Biosynthesis of lipoproteins, 2nd ed., vol. 1.
ASM Press, Washington, D.C.
|
| 32.
|
Yamaguchi, K.,
F. Yu, and M. Inouye.
1988.
A single amino acid determinant of the membrane localization of lipoproteins in E. coli.
Cell
53:423-432[Medline].
|
| 33.
|
Zgurskaya, H. I., and H. Nikaido.
1999.
ArcA is a highly asymmetric protein capable of spanning the periplasm.
J. Mol. Biol.
285:409-420[Medline].
|
Journal of Bacteriology, December 1999, p. 7285-7290, Vol. 181, No. 23
0021-9193/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Ahn, I.-P., Kim, S., Lee, Y.-H.
(2005). Vitamin B1 Functions as an Activator of Plant Disease Resistance. Plant Physiol.
138: 1505-1515
[Abstract]
[Full Text]
-
Skovran, E., Lauhon, C. T., Downs, D. M.
(2004). Lack of YggX Results in Chronic Oxidative Stress and Uncovers Subtle Defects in Fe-S Cluster Metabolism in Salmonella enterica. J. Bacteriol.
186: 7626-7634
[Abstract]
[Full Text]
-
Wunsch, P., Herb, M., Wieland, H., Schiek, U. M., Zumft, W. G.
(2003). Requirements for CuA and Cu-S Center Assembly of Nitrous Oxide Reductase Deduced from Complete Periplasmic Enzyme Maturation in the Nondenitrifier Pseudomonas putida. J. Bacteriol.
185: 887-896
[Abstract]
[Full Text]
-
Skovran, E., Downs, D. M.
(2003). Lack of the ApbC or ApbE Protein Results in a Defect in Fe-S Cluster Metabolism in Salmonella enterica Serovar Typhimurium. J. Bacteriol.
185: 98-106
[Abstract]
[Full Text]
-
Gralnick, J., Downs, D.
(2001). Protection from superoxide damage associated with an increased level of the YggX protein in Salmonellla enterica. Proc. Natl. Acad. Sci. USA
10.1073/pnas.151243198v1
[Abstract]
[Full Text]
-
Gralnick, J., Webb, E., Beck, B., Downs, D.
(2000). Lesions in gshA (Encoding gamma -L-Glutamyl-L-Cysteine Synthetase) Prevent Aerobic Synthesis of Thiamine in Salmonella enterica Serovar Typhimurium LT2. J. Bacteriol.
182: 5180-5187
[Abstract]
[Full Text]
-
Gralnick, J., Downs, D.
(2001). Protection from superoxide damage associated with an increased level of the YggX protein in Salmonella enterica. Proc. Natl. Acad. Sci. USA
98: 8030-8035
[Abstract]
[Full Text]